← Back to headlines
Novo Nordisk and Hims & Hers Deal Benefits Both Stocks
A new deal between pharmaceutical giant Novo Nordisk and health platform Hims & Hers is expected to yield positive outcomes for the stock performance of both companies.
16 Mar, 13:20 — 16 Mar, 13:20
Sources
Showing 1 of 1 sources
